BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28556305)

  • 1. Hypothalamic dopamine is required for salsolinol-induced prolactin secretion in goats.
    Hashizume T; Watanabe R; Inaba Y; Sawai K; Fülöp F; Nagy GM
    Anim Sci J; 2017 Oct; 88(10):1588-1594. PubMed ID: 28556305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of extracerebral dopamine on salsolinol- or thyrotropin-releasing hormone-induced prolactin (PRL) secretion in goats.
    Inaba Y; Kato Y; Itou A; Chiba A; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2016 Dec; 87(12):1522-1527. PubMed ID: 26997651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats.
    Jin J; Hara S; Sawai K; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2014 Apr; 85(4):461-7. PubMed ID: 24329779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J; Hashizume T
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine inhibits salsolinol-induced prolactin release in male goats.
    Hashizume T; Sawada T; Nakajima Y; Yaegashi T; Saito H; Goto Y; Jin J; Fülöp F; Nagy GM
    Anim Sci J; 2012 Jan; 83(1):63-7. PubMed ID: 22250741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of photoperiod on salsolinol-induced prolactin secretion in goats.
    Yaegashi T; Jin J; Sawada T; Saito H; Fülöp F; Nagy GM; Hashizume T
    Anim Sci J; 2012 May; 83(5):418-25. PubMed ID: 22574794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of melatonin on salsolinol-induced prolactin secretion in goats.
    Hashizume T; Yaegashi T; Jin J; Sawai K; Fülöp F; Nagy GM
    Anim Sci J; 2013 Apr; 84(4):334-40. PubMed ID: 23590508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion after hypothalamic deafferentation in beef calves: response to haloperidol, alpha-methyl-rho-tyrosine, thyrotropin-releasing hormone and ovariectomy.
    Benoit AM; Molina JR; Lkhagvadorj S; Anderson LL
    Anim Reprod Sci; 2009 Mar; 111(1):54-68. PubMed ID: 18359173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
    Homicskó KG; Kertész I; Radnai B; Tóth BE; Tóth G; Fülöp F; Fekete MI; Nagy GM
    Neurochem Int; 2003 Jan; 42(1):19-26. PubMed ID: 12441164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of prolactin-releasing response to salsolinol in vivo in cattle.
    Hashizume T; Sawada T; Yaegashi T; Saito H; Ahmed AE; Goto Y; Nakajima Y; Jin J; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2010 Jul; 39(1):21-5. PubMed ID: 20172684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salsolinol is present in the bovine posterior pituitary gland and stimulates the release of prolactin both in vivo and in vitro in ruminants.
    Hashizume T; Shida R; Suzuki S; Nonaka S; Yonezawa C; Yamashita T; Kasuya E; Sutoh M; Oláh M; Székács D; Nagy GM
    Domest Anim Endocrinol; 2008 Feb; 34(2):146-52. PubMed ID: 17267162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE
    J Clin Endocrinol Metab; 1986 Jul; 63(1):249-51. PubMed ID: 3086358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
    Timmerman W; Poelman RT; Westerink BH; Schuiling GA
    Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
    Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
    Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CNS dopamine augmentation on stimulated prolactin secretion.
    Woolf PD; Leebaw WJ; Lee LA
    J Clin Endocrinol Metab; 1977 Oct; 45(4):857-60. PubMed ID: 410827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA; Frohman LA
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.